Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Repurposing anti-cancer drugs for COVID-19 treatment
Nicholas Borcherding
, Yogesh Jethava
, Praveen Vikas
Division of Laboratory and Genomic Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Repurposing anti-cancer drugs for COVID-19 treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Repurposing
100%
COVID-19
100%
Anticancer Drugs
100%
Effective Compounds
33%
Clinical Trials
16%
Adverse Events
16%
Cell Division
16%
Inflammation
16%
Infectious Diseases
16%
Drug Development
16%
Drug pipeline
16%
Coronavirus
16%
Treatment Trials
16%
Allergy Disease
16%
Drug Discovery
16%
Johns Hopkins University
16%
Existing Drugs
16%
COVID-19 Pandemic
16%
Novel Vaccines
16%
Human Life
16%
Safety Assessment
16%
Compassionate Use
16%
Resource Center
16%
Drug Repurposing
16%
Use Studies
16%
Host Microenvironment
16%
Social Hardship
16%
Financial Hardship
16%
Remdesivir
16%
Efficacy Evaluation
16%
Emergency Authorisation
16%
Remdesivir Treatment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Repurposing
100%
Anticarcinogen
100%
Coronavirinae
100%
Diseases
100%
Drug Discovery
28%
Remdesivir
28%
Clinical Trial
14%
Malignant Neoplasm
14%
Adverse Event
14%
Inflammation
14%
Drug Development
14%
Pandemic
14%
Drug Repositioning
14%